Visual Gains with Faricimab vs Aflibercept 8 mg in Naïve Retinovascular Disease: Global Real-World Cases and Literature Review
Clinical Ophthalmology · 2026-07 · Volume 20 · 1-14
DOI: 10.2147/opth.s622037 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Ophthalmology, 2026-07. Verfasst von Hana A Mansour und 37 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology (H.A.M., W.K., A.M.M.), American University of Beirut, Beirut, Lebanon. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology (H.A.M., W.K., A.M.M.), American University of Beirut, Beirut, Lebanon.
- Hôpital Ophtalmique Jules-Gonin (C.H.E., S.M.), Fondation Asile des Aveugles, Lausanne, Switzerland.
- Department of Surgical Science (C.H.E.), University of Torino, Torino, Italy.
- Department of Ophthalmology and Visual Sciences (F.P.), University of Toronto, Toronto, Canada.
- Cincinnati Eye Institute (R.E.F.), Cincinnati, OH, USA.
- Department of Epidemiology and Population Health (S.A.C.), American University of Beirut, Beirut, Lebanon.
ORCID-Profile: Francesco Pichi, Abdallah A Ellabban, Silvana Belotto, Hashem Abu Serhan, Eduardo Pérez-Salvador García, Stephen G Schwartz, Ignasi Jürgens, Antonio M B Casella, Luiz H Lima, Suthasinee Sinawat, Wajiha J Kheir, Ayman G Elnahry, Ahmad M Mansour
Zitieren
APA
Mansour, H. A., Eandi, C. M., Pichi, F., Foster, R. E., Charbaji, S. A., Chakraborty, D., Ellabban, A. A., Belotto, S., Abu Serhan, H., Magnin, S., Lopez-Guajardo, L., Pérez-Salvador García, E., Schwartz, S. G., Stewart, M. W., Rey, A., Jürgens, I., Casella, A. M. B., Upadhyay, A., Sheth, J. U., …, & Mansour, A. M. (2026). Visual Gains with Faricimab vs Aflibercept 8 mg in Naïve Retinovascular Disease: Global Real-World Cases and Literature Review. Clinical Ophthalmology, Volume 20, 1-14. https://doi.org/10.2147/opth.s622037
Vancouver
Mansour HA, Eandi CM, Pichi F, Foster RE, Charbaji SA, Chakraborty D, et al. Visual Gains with Faricimab vs Aflibercept 8 mg in Naïve Retinovascular Disease: Global Real-World Cases and Literature Review. Clinical Ophthalmology. 2026;Volume 20:1-14. doi:10.2147/opth.s622037
BibTeX
@article{Mansour2026,
author = {Mansour, Hana A and Eandi, Chiara M and Pichi, Francesco and Foster, Robert E and Charbaji, Suzanne A and Chakraborty, Debdulal and Ellabban, Abdallah A and Belotto, Silvana and Abu Serhan, Hashem and Magnin, Simon and Lopez-Guajardo, Lorenzo and Pérez-Salvador García, Eduardo and Schwartz, Stephen G and Stewart, Michael W and Rey, Amanda and Jürgens, Ignasi and Casella, Antonio M B and Upadhyay, Anubhav and Sheth, Jay U and Lima, Luiz H and Sinawat, Suthasinee and Abengoechea, Santiago and Capella, Maria Jose and Viver Oller, Sonia and Elizalde, Javier and Kheir, Wajiha J and Mammo, Danny and Barbosa, Gabriel Castilho Sandoval and Villegas, Victor M and Desai, Arjun and Tripathy, Koushik and Bala, Suraj and Mohan, Nitesh and Elnahry, Ayman G and Uwaydat, Sami H and Cherfan, Daniel G and Parodi, Maurizio Battaglia and Mansour, Ahmad M},
title = {Visual Gains with Faricimab vs Aflibercept 8 mg in Naïve Retinovascular Disease: Global Real-World Cases and Literature Review},
journal = {Clinical Ophthalmology},
year = {2026},
volume = {Volume 20},
pages = {1--14},
doi = {10.2147/opth.s622037}
}
EUVIMED